Literature DB >> 8420477

Cochlear pathology in presbycusis.

H F Schuknecht1, M R Gacek.   

Abstract

A survey of the temporal bone collection at the Massachusetts Eye and Ear Infirmary reveals 21 cases that meet the criterion for the clinical diagnosis of presbycusis. It is evident that the previously advanced concept of four predominant pathologic types of presbycusis is valid, these being sensory, neural, strial, and cochlear conductive. An abrupt high-tone loss signals sensory presbycusis, a flat threshold pattern is indicative of strial presbycusis, and loss of word discrimination is characteristic of neural presbycusis. When the increments of threshold loss present a gradually decreasing linear distribution pattern on the audiometric scale and have no pathologic correlate, it is speculated that the hearing loss is caused by alterations in the physical characteristics of the cochlear duct, and the loss is identified as cochlear conductive presbycusis. It is clear that many individual cases do not separate into a specific type but have mixtures of these pathologic types and are termed mixed presbycusis. About 25% of all cases of presbycusis show none of the above characteristics and are classified as indeterminate presbycusis.

Entities:  

Mesh:

Year:  1993        PMID: 8420477     DOI: 10.1177/00034894931020S101

Source DB:  PubMed          Journal:  Ann Otol Rhinol Laryngol        ISSN: 0003-4894            Impact factor:   1.547


  211 in total

Review 1.  Hearing impairment in older people: a review.

Authors:  L Fook; R Morgan
Journal:  Postgrad Med J       Date:  2000-09       Impact factor: 2.401

2.  Metabolic presbycusis: differential changes in auditory brainstem and otoacoustic emission responses with chronic furosemide application in the gerbil.

Authors:  David M Mills; Richard A Schmiedt
Journal:  J Assoc Res Otolaryngol       Date:  2003-11-20

3.  Why do hair cells and spiral ganglion neurons in the cochlea die during aging?

Authors:  Philip Perez; Jianxin Bao
Journal:  Aging Dis       Date:  2011-04-28       Impact factor: 6.745

4.  Chronic reduction of endocochlear potential reduces auditory nerve activity: further confirmation of an animal model of metabolic presbyacusis.

Authors:  Hainan Lang; Vinu Jyothi; Nancy M Smythe; Judy R Dubno; Bradley A Schulte; Richard A Schmiedt
Journal:  J Assoc Res Otolaryngol       Date:  2010-04-06

Review 5.  Effects of caloric restriction on age-related hearing loss in rodents and rhesus monkeys.

Authors:  Shinichi Someya; Masaru Tanokura; Richard Weindruch; Tomas A Prolla; Tatsuya Yamasoba
Journal:  Curr Aging Sci       Date:  2010-02

6.  Alström Syndrome protein ALMS1 localizes to basal bodies of cochlear hair cells and regulates cilium-dependent planar cell polarity.

Authors:  Daniel Jagger; Gayle Collin; John Kelly; Emily Towers; Graham Nevill; Chantal Longo-Guess; Jennifer Benson; Karin Halsey; David Dolan; Jan Marshall; Jürgen Naggert; Andrew Forge
Journal:  Hum Mol Genet       Date:  2010-11-11       Impact factor: 6.150

7.  Expression pattern of oxidative stress and antioxidant defense-related genes in the aging Fischer 344/NHsd rat cochlea.

Authors:  Chiemi Tanaka; Donald E Coling; Senthilvelan Manohar; Guang-Di Chen; Bo Hua Hu; Richard Salvi; Donald Henderson
Journal:  Neurobiol Aging       Date:  2012-02-01       Impact factor: 4.673

Review 8.  The role of glucocorticoids for spiral ganglion neuron survival.

Authors:  David Xu Jin; Zhaoyu Lin; Debin Lei; Jianxin Bao
Journal:  Brain Res       Date:  2009-02-21       Impact factor: 3.252

9.  Heptanol application to the mouse round window: a model for studying cochlear lateral wall regeneration.

Authors:  Shawn M Stevens; Yazhi Xing; Christopher T Hensley; Juhong Zhu; Judy R Dubno; Hainan Lang
Journal:  Otolaryngol Head Neck Surg       Date:  2014-01-16       Impact factor: 3.497

Review 10.  Application of Mouse Models to Research in Hearing and Balance.

Authors:  Kevin K Ohlemiller; Sherri M Jones; Kenneth R Johnson
Journal:  J Assoc Res Otolaryngol       Date:  2016-10-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.